Breathlessness Rapid Evaluation and THErapy (BREATHE)

Study identification

• EU PAS number:
  EUPAS1000000018
• Study ID:
  1000000018
• Official title and acronym:
  Breathlessness Rapid Evaluation and THErapy (BREATHE)
• DARWIN EU® study:
  No
• Study countries:
  Australia

  United Kingdom
• Study description:
  To develop an algorithm to predict the probability of different conditions relating to breathlessness based on demographic, presenting symptoms, observations, diagnostic test results and treatments. The aim of the algorithm is to optimise assessment pathway based on evidence and reduce the time taken for a patient to receive an accurate diagnosis of conditions causing their presenting breathlessness.
• Study status:
  Ongoing

Research institutions and networks

Institutions

The George Institute for Global Health, UNSW Sydney

Networks

Optimum Patient Care (OPC) Network

United Kingdom (Northern Ireland)

Study timelines

Date when funding contract was signed

Planned:01/04/2023

Actual:01/04/2023

Study start date

Planned:01/12/2023

Actual:26/01/2024

Date of final study report

Planned:30/09/2024

Sources of funding

Other public funding (e.g. hospital or university)

More details on funding

Australian Government Medical Research Future Fund (MRFF)

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only